...
首页> 外文期刊>BMC Pregnancy and Childbirth >Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda
【24h】

Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda

机译:在乌干达西部横断队列中,用于预防艾滋病毒垂直传播的备选方案B +对不良出生结局没有影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background While most Sub-Saharan African countries are now implementing the WHO-recommended Option B+ protocol for prevention of vertical HIV transmission, there is a lack of knowledge regarding the influence of Option B+ exposure on adverse birth outcomes (ABOs). Against this background, we assessed ABOs among delivering women in Western Uganda. Methods A cross-sectional, observational study was performed within a cohort of 412 mother-newborn-pairs in Virika Hospital, Fort Portal in 2013. The occurrence of stillbirth, pre-term delivery, and small size for gestational age (SGA) was analysed, looking for influencing factors related to HIV-status, antiretroviral drug exposure and duration, and other sociodemographic and clinical parameters. Results Among 302 HIV-negative and 110 HIV-positive women, ABOs occurred in 40.5%, with stillbirth in 6.3%, pre-term delivery in 28.6%, and SGA in 12.2% of deliveries. For Option B+ intake ( n =?59), no significant association was found with stillbirth (OR 0.48, p =?0.55), pre-term delivery (OR 0.97, p =?0.92) and SGA (OR 1.5, p =?0.3) compared to seronegative women. Women enrolled on antiretroviral therapy (ART) before conception ( n =?38) had no different risk for ABOs than women on Option B+ or HIV-negative women. Identified risk factors for stillbirth included lack of formal education, poor socio-economic status, long travel distance, hypertension and anaemia. Pre-term delivery risk was increased with poor socio-economic status, primiparity, Malaria and anaemia. The occurrence of SGA was influenced by older age and Malaria. Conclusion In our study, women on Option B+ showed no difference in ABOs compared to HIV-negative women and to women on ART. We identified several non-HIV/ART-related influencing factors, suggesting an urgent need for improving early risk assessment mechanisms in antenatal care through better screening and triage systems. Our results are encouraging with regard to continued universal scale-up of Option B+ and ART programmes.
机译:背景信息虽然大多数撒哈拉以南非洲国家现在正在执行世卫组织推荐的预防B +方案,以预防艾滋病毒的垂直传播,但缺乏关于B +方案暴露对不良出生结局(ABO)的影响的知识。在此背景下,我们评估了乌干达西部交付妇女中的ABO。方法2013年在Fort Portal的Virika医院的412例新生儿对中进行了横断面观察研究。分析了死胎,早产和小胎龄(SGA)的发生,寻找与HIV状况,抗逆转录病毒药物的暴露量和持续时间以及其他社会人口统计学和临床​​参数有关的影响因素。结果在302例HIV阴性和110例HIV阳性女性中,ABO发生率为40.5%,死产为6.3%,早产为28.6%,SGA为分娩的12.2%。对于选项B +摄入量(n =?59),与死胎(OR 0.48,p =?0.55),早产(OR 0.97,p =?0.92)和SGA(OR 1.5,p =? 0.3)的女性。在受孕前接受抗逆转录病毒疗法(ART)的女性(n = 38)与选择B +或HIV阴性女性相比没有发生ABO的风险。确定的死产危险因素包括缺乏正规教育,社会经济地位差,旅行距离长,高血压和贫血。社会经济地位差,初产,疟疾和贫血会增加早产风险。 SGA的发生受年龄和疟疾的影响。结论在我们的研究中,与HIV阴性女性和抗逆转录病毒治疗女性相比,采用方案B +的女性没有表现出ABO差异。我们确定了几个非HIV / ART相关的影响因素,这表明迫切需要通过更好的筛查和分类系统来改善产前护理的早期风险评估机制。关于方案B +和ART方案的持续普遍扩大,我们的结果令人鼓舞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号